1,425 pharmaceutical and medication recalls tracked. Stay informed about FDA drug safety alerts, prescription medications, over-the-counter drugs, and dietary supplements.
Looking for a specific drug? Use the search page to find recalls by medication name, manufacturer, or NDC number.
AstraZeneca recalled 916 pre-filled syringes of Fasenra on October 8, 2025. The recall follows a lack of assurance of sterility, posing serious health risks. Consumers and healthcare providers must stop using the product immediately.
Rising Pharma Holdings recalled 2,064 bottles of Carbidopa, Levodopa, Entacapone tablets on October 7, 2025. The recall followed reports that bottles contained incorrect dosages. The affected product poses a high risk due to potential overdose.
Zydus Lifesciences recalled 13,080 bottles of Tavaborole topical solution on October 6, 2025, due to discoloration. The recall affects products distributed nationwide in the USA. Consumers must stop using the product immediately and contact their healthcare providers for guidance.
Advanced Pharmaceutical Technology recalled 22,843 cartons of TESTO-100 CIII testosterone pellets on October 3, 2025. The recall follows a risk of microbial contamination that could compromise product sterility. Consumers and healthcare providers should stop using the product immediately and seek guidance.
Almpal recalled dissolved oxygen test kits on October 2, 2025. The kits contain unchild-resistant sulfuric acid, posing a poisoning risk to children. Consumers should stop using these kits immediately and secure them out of reach of children.
ICU Medical recalled 23,203 IV administration sets on October 2, 2025. The sets lack an internal shutoff valve, risking fluid over-delivery and air infusion. This recall affects devices distributed worldwide, including the U.S., Canada, Australia, and New Zealand.
Camber Pharmaceuticals, Inc. recalled Ketorolac Tromethamine Injection on October 1, 2025. The recall affects a specific lot due to the presence of glass particles. This recall pertains to the 60 mg/2 mL single-dose vials distributed nationwide.
Church & Dwight Co., Inc. recalled 21,912 bottles of ZICAM Medicated Fruit Drops on October 1, 2025. The recall stems from a labeling mix-up that failed to disclose elderberry as an ingredient. Consumers should stop using the product immediately.
Abiomed issued a recall for 10,153 Automated Impella Controllers on October 1, 2025. The devices face potential cybersecurity vulnerabilities related to their operating system. Healthcare providers and patients should stop using these devices immediately.
SHENZHEN ATOMSTACK TECHNOLOGIES recalled material processing laser products on September 30, 2025, due to a missing remote interlock connector. This defect poses a high risk according to federal regulations. Consumers should stop using these devices immediately and follow manufacturer instructions for remedy.
B BRAUN MEDICAL recalled 1,298,454 hemodialysis bloodlines on September 30, 2025. The recall results from the risk of micro-air bubbles due to damaged connectors. Patients should stop using the product immediately and follow the manufacturer’s instructions.
AFCO recalled hand sanitizer on September 29, 2025, due to a risk of methanol contamination. The company failed to conduct required testing on incoming alcohol components. Consumers should stop using the product immediately.
Medline Industries recalled 222,800 boxes of alcohol prep pads on September 29, 2025. The recall follows concerns the product may not meet potency standards. Consumers must stop using the pads and seek guidance from healthcare providers.
Philips Medical Systems Nederland B.V. recalled 29 Zenition 50 x-ray systems on September 29, 2025. The devices may suffer from corrosion of the Image Intensifier Television control board, leading to poor image quality. Users must stop using the device immediately and follow the recall instructions.
Acuity Specialty Products recalled its Wyandotte Sanifect E3 hand sanitizer on September 29, 2025. The recall affects multiple package configurations due to potential methanol contamination. Consumers should stop using the product immediately and contact the company for guidance.
Acella Pharmaceuticals recalled 4,680 bottles of Doxycycline Hyclate Tablets on September 29, 2025. The recall follows failed dissolution specifications, which can affect medication efficacy. This recall includes 500-count bottles distributed nationwide in the USA.
Synthes (USA) Products LLC recalled 122 surgical screws on September 26, 2025. Mislabeling of screw lengths poses a serious risk to patients. Affected products include those used in the RFN-ADVANCED and Tibial Nail Advanced Systems.
Dr. Reddy's Laboratories recalled 571 vials of Succinylcholine Chloride Injection on September 26, 2025. The recall stems from out-of-specification results during stability testing, indicating a decreased preservative concentration. The product is used for intravenous or intramuscular administration and is available by prescription only.
Synthes (USA) Products LLC recalled 120 units of medical screws on September 26, 2025. The screws were incorrectly labeled, posing a risk to patients. The recall affects multiple states and Canada.
Mad Rabbit recalled its "RELIEVE" numbing cream on September 25, 2025. This recall affects the product due to non-compliance with child-resistant packaging requirements. The cream poses a risk of serious injury or death from poisoning if ingested by young children.
DJO recalled 1,594 cold compression wraps on September 25, 2025. The wraps may leak or break when heated in the microwave, posing a burn risk. The recall affects models REF: DP163CT03-BLK-L, XL, and DP163CT02.
LeMaitre Vascular recalled one unit of its Collagen Vascular Graft on September 25, 2025. The device was packed in the wrong size labeled outer packaging, posing a high hazard to patients. Health providers and patients should stop using this device immediately and follow the recall instructions.
Aloe Up recalled 11,386 tubes of Sport Performance Sunscreen Lotion SPF 30 on September 25, 2025. The recall follows cGMP deviations resulting in failed microbial count testing. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Zydus Pharmaceuticals recalled 600 bottles of Entecavir Tablets on September 24, 2025. The recall follows a failed impurity specification that poses health risks. Consumers should stop using the product immediately and contact healthcare providers for guidance.
Receive immediate notifications when medications you care about are recalled. Stay safe with timely FDA drug safety alerts.